Product Images Stalevo

Stalevo® 100 is a prescription medication that contains carbidopa USP 25 mg, levodopa USP 100 mg, and entacapone 200 mg. It is recommended to swallow the tablets whole and not crush, split or chew them. The drug should be kept in a tight container and stored at a temperature between 15°C to 30°C (59°F to 86°F). It is manufactured by Orion Corporation in Finland and distributed by Almatica Pharma LLC in Morristown, NJ. Combining tablets to achieve a higher strength is not recommended because of the risk of entacapone overdose. The dosage information can be found in the package insert.*

This is a prescription drug marketed as Stalevo. The package contains tablets with a combination of carbidopa, levodopa, and entacapone. The dosages are not mentioned, but the package insert should be referred to. The tablets should be swallowed whole and should not be chewed, crushed, or spat out. It should be kept in a tight container at a temperature of 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). This drug is intended for adult use only, and all drugs should be kept out of the reach of children. Do not attempt to combine tablets to achieve a higher strength, as it will increase the risk of entacapone overdose. The drug is manufactured by the Orion Corporation, Finland, and distributed by Amaica Pharma LLC, Morristown, NJ. The lot and expiry dates are not mentioned in the text.*

Stalevo® 150 is a medication consisting of carbidopa USP of 37.5 mg, levodopa USP of 150 mg, and entacapone of 200 mg. It is supplied in a prescription-only bottle of 100 tablets. Patients are advised not to increase the strength of the tablets to avoid overdose. The medication must be stored in a cool, dry place and kept out of the reach of children. Stalevo® 150 was manufactured by Orion Corporation in Finland and is distributed in the US by Almatica Pharma LLC.*

This is a medication package for Stalevo 200, containing 100 tablets. Each tablet contains 50 mg of carbidopa USP and 200 mg of levodopa USP, in addition to 200 mg of entacapone. The medication should only be taken as prescribed and should not be crushed or chewed. It should be stored in a tight container at room temperature (15°C to 30°C) and kept out of reach of children. The medication is manufactured by Orion Corporation in Finland and distributed by Amatica Pharma LLC in Worristown, NJ. It is important not to combine tablets to achieve a higher strength or risk an overdose of entacapone.*

Stalevo® 50 is a medication containing carbidopa USP 12.5 mg, levodopa USP 50 mg, and entacapone 200 mg. It is used for the management of Parkinson's disease symptoms in adults. The medication should be stored at 25°C (77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). The medication should only be taken as directed with a prescription. The manufacturer of this medication is Orion Corporation, and it is distributed by Almatica Pharma LLC. The tablets should not be combined to achieve a higher strength due to the risk of entacapone overdose.*

This text corresponds to the description and instructions for use of Stalevo® 75, a medication composed of carbidopa USP 18.75mg, levodopa USP 75mg, and entacapone 200mg, distributed by Orion Corporation and Amaiica Pharma LG. The product comes in the form of 100 tablets and should be swallowed whole, not crushed, split, or chewed. Users are warned not to combine tablets to achieve a higher strength and should follow the dosage instructions provided in the package. The medication should be stored in a tight container, at a temperature of 25°C (77°F), with excursions permitted between 15°C to 100°C (59°F to 86°F), and kept out of reach of children.*